A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
The scientists found that over-activation of a certain protein in hormone-secreting cells helps fuel medullary thyroid cancer cells in mice as well as in human cells, making the protein a potentially good target for therapies to inhibit the growth of these cancer cells.
The discovery by the multidisciplinary team at UT Southwestern has implications for neuroendocrine cancers that arise in organs farther removed from the brain, including the lung and the pancreas.
Although rare, medullary thyroid cancer is often fatal.
“Once or twice a month, patients come to UT Southwestern, often complaining of soreness or a swollen throat,” says Dr. Fiemu Nwariaku, Professor of Surgery and a co-author on the paper. “When the diagnosis is a rare and incurable form of thyroid cancer called medullary thyroid carcinoma, it is always distressing for the patient – and for me – because we currently have no real therapies that truly extend life in these unfortunate cases.”
The only effective treatment is complete surgical removal of the thyroid, and frequently, tissues around the area of the tumor. Unfortunately, like cervical cancer, medullary thyroid cancer often is not diagnosed until it already has spread to other parts of the body.
More than 20 years ago, mutations in a gene were found to cause about 25 percent of these cancers. Genetic sequencing and screening has become an important diagnostic and prognostic tool for those families that share such mutations. But the causes for the remaining 75 percent of patients with this dangerous cancer have remained unknown and a source of frustration for endocrinologists and surgeons such as Dr. Nwariaku, also Associate Dean of Global Health.
While Dr. Nwariaku and his colleagues work to treat these patients, a laboratory in UT Southwestern’s Department of Psychiatry run by Dr. James Bibb, Associate Professor of Psychiatry and Neurology and Neurotherapeutics, was studying molecular mechanisms of brain disorders. In studying Alzheimer’s and other forms of dementia, Dr. Bibb and his colleagues made a transgenic mouse model of brain injury by overexpressing the Cdk5 protein that they thought was only in the brain.
As the team tracked the developing neurological problems, however, they noted that the mice became sick for reasons that were not at first apparent. The puzzle was solved when they discovered that all of the mice had developed the same thyroid cancer that Dr. Nwariaku treats.
Dr. Bibb and Dr. Nwariaku teamed up and launched a study of both human and mouse thyroid cancer cells. They discovered that Cdk5 was present in specific cells of the thyroid called C cells, and that the protein could escape normal cellular control and cause the cancer in both humans and mice.
Now, with the help of other UT Southwestern scientists, Dr. Bibb and Dr. Nwariaku, both members of the Harold C. Simmons Cancer Center, are making important progress in their efforts to develop new treatments for this and other more common forms of endocrine cancers. One promising example is the use of high-throughput screening for compounds that block the Cdk5 protein pathway, the researchers said.
“There are currently two FDA-approved drugs for treating neuroendocrine cancers, but neither of them blocks this specific pathway – one this study has shown to be a crucial vulnerability in the cancer, if appropriately targeted,” Dr. Bibb said. “We were surprised, but encouraged, by the finding because they link the human nervous system to disease processes that include the toughest of all foes, cancer.”
Other researchers participating in the study included Dr. James Richardson, Professor of Pathology, Molecular Biology, and Plastic Surgery, who first recognized the disease in the mouse, and Dr. Xiankai Sun, Associate Professor of Radiology, who was able to track the development of the mouse tumors using advanced in vivo imaging. The work also includes an international collaboration of scientists and physicians who contributed insight and rare samples for the investigation. The research is being funded by the American Cancer Society.
“This research is ongoing, and we are now identifying precisely how Cdk5 causes the growth and spread of these forms of cancer with the goal of discovering new drugs, which we can test in our animal model,” Dr. Bibb said. “We want to work together to translate our laboratory bench-derived insight into treatments that help cancer patients. We also think we will learn more about brain injury by studying this cancer.”
Visit UT Southwestern’s Harold C. Simmons Cancer Center to learn more about cancer research, screening, and therapy at UT Southwestern, including highly individualized treatments at the region’s only National Cancer Institute-designated center.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 90,000 hospitalized patients and oversee more than 1.9 million outpatient visits a year.
This news release is available on our home page at
To automatically receive news releases from UT Southwestern via email, subscribe at utsouthwestern.edu/receivenews
Dr. Nwariaku holds the Malcolm O. Perry, M.D. Professorship in Surgery.
Dr. Sun holds the Dr. Jack Krohmer Professorship in Radiation Physics.
Alex Lyda | Source: Newswise
Further information: www.utsouthwestern.edu
Further Reports about: brain injury > Cancer > cancer cells > certain > disease process > human cell > Medical Wellness > molecular mechanism > neurological problem > Prostate Surgery > Protein > Southwestern > Thyroid > thyroid cancer
More articles from Life Sciences:
How Sugar Molecules Influence Embryonic Development
18.12.2013 | Ruprecht-Karls-Universität Heidelberg
Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior
18.12.2013 | DOE/Oak Ridge National Laboratory
A 12-year study of massive stars has reaffirmed that our Galaxy has four spiral arms, following years of debate sparked by images taken by NASA's Spitzer Space Telescope that only showed two arms.
The new research, which is published online today [17 December] in the Monthly Notices of the Royal Astronomical Society, is part of the RMS Survey, which was launched by academics at the University of Leeds.
Astronomers cannot see what our Galaxy, which is called the Milky Way, looks like because we ...
In collaboration with the University of Basel, an international team of researchers has observed a strong energy loss caused by frictional effects in the vicinity of charge density waves.
This may have practical significance in the control of nanoscale friction. The results have been published in the scientific journal Nature Materials.
Friction is often seen as an adverse phenomenon that leads to wear and causes energy loss. Conversely, however, too little friction can be a disadvantage as well – ...
A new type of transistor that could make possible fast and low-power computing devices for energy-constrained applications such as smart sensor networks, implantable medical electronics and ultra-mobile computing is feasible, according to Penn State researchers.
Called a near broken-gap tunnel field effect transistor (TFET), the new device uses the quantum mechanical tunneling of electrons through an ultrathin energy barrier to provide high current at low voltage.
Penn State, the National Institute of Standards and Technology and IQE, a specialty wafer manufacturer, jointly presented their findings at ...
The team of Johannes Zuber at the IMP in Vienna, Austria, managed to overcome remaining key limitations of RNA interference (RNAi) - a unique method to specifically shut off genes.
By using an optimized design, the scientists were able to inhibit genes with greatly enhanced efficiency and accuracy. The new method facilitates the search for drug targets and improves the interpretation of experimental results.
The IMP will make this „RNAi toolkit“ available to researchers. Results of the study are published in ...
Research The dangerous parasite Schistosoma mansoni that causes snail fever in humans could become significantly less common in the future a new international study led by researchers from the University of Copenhagen predicts.
The results are surprising because they contradict the general assumption that climate change leads to greater geographical spread of diseases. The explanation is that the parasite’s host snails stand to lose suitable habitat due to climate change.
“Our research shows that the expected effects of climate change will lead ...
18.12.2013 | Life Sciences
18.12.2013 | Medical Engineering
18.12.2013 | Studies and Analyses
11.12.2013 | Event News
10.12.2013 | Event News
05.12.2013 | Event News